Thermo Fisher’s EXENT Solution received IVDR Certification. Credit: Thermo Fisher Scientific.

Thermo Fisher Scientific has commercially introduced its fully integrated and automated mass spectrometry system, EXENTSolution.

The system is now available commercially in the UK, the Netherlands, Spain, Italy, Germany, France and Belgium.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

EXENTSolution, which received in vitro diagnostic regulation (IVDR) certification, is intended to diagnose and evaluate patients with monoclonal gammopathies, including multiple myeloma.

Clinical laboratories can use the system for measuring, quantifying and tracking endogenous M-proteins and exogenous therapeutic monoclonal antibodies with improved analytical sensitivity and specificity in serum.

It features the EXENT-iP 500 automated sample preparation instrument, the EXENT-iX500 matrix-assisted laser desorption ionisation time of flight mass spectrometer and the EXENT-iQ intelligent and workflow software with data review.

See Also:

To measure and quantify IgG, IgA, and IgM, the analyser is integrated with the EXENTimmunoglobulin isotypes immunoassay.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Developed utilising intellectual property from Mayo Clinic, the solution has key features, including dynamic monitoring of unique M-proteins and better visualisation.

Other features include simplified and less invasive serum testing, smart software with automated algorithm data processing and quantification with the Optilite analyser.

Thermo Fisher Protein Diagnostics chief scientific officer Dr Stephen Harding said: “The EXENT Solution represents a significant breakthrough in innovation for the detection and monitoring of monoclonal immunoglobulins.”

At the start of this year, the company concluded the acquisition of the Binding Site, adding protein diagnostics solutions that included diagnosis and monitoring for monoclonal gammopathies to its speciality diagnostics portfolio.